Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 21, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data.

Jieping Ye¹, Michael Farnum, Eric Yang

¹Center for Evolutionary Medicine and Informatics, The Biodesign Institute, Arizona, State University, Tempe, AZ, USA. jieping.ye@asu.edu

|June 27, 2012

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Identifying the window of aggressive postpartum breast cancer based on the 21-gene Oncotype DX® test in women with HR+, HER2-negative breast cancer.

NPJ breast cancer·2026

Same author

Climate dependent feasibility of closing water and nutrient cycles in industrial aqua-agriculture.

iScience·2026

Same author

Sleep and Activity Patterns in Depression From Wearable Data: Unsupervised Clustering Study.

Journal of medical Internet research·2026

Same author

Histological study to assess CO<sub>2</sub> laser therapy for the treatment of vaginal atrophy.

European journal of obstetrics, gynecology, and reproductive biology·2026

Same author

Normative cognitive data and psychometric validation of the 10/66 harmonized assessment protocol in Latin American.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Same author

A Maturity Model for REDCap-Based Patient-Facing Technologies: A Roadmap Toward Patient-Centered Intelligence.

Studies in health technology and informatics·2026

Same journal

The relationship between physical activity levels and measures of cognition and disease severity in prodromal Parkinson's disease: A longitudinal study.

BMC neurology·2026

Same journal

Aseptic meningitis as an uncommon presentation of polyarteritis nodosa: a case report with focused literature synthesis.

BMC neurology·2026

Same journal

Preliminary effects of intermittent theta burst stimulation combined with virtual reality-based cycling training on upper extremity function in children with cerebral palsy: a double-blind randomized crossover trial.

BMC neurology·2026

Same journal

Factors associated with symptom relief and lesion formation in acute ischemic stroke and transient ischemic attack.

BMC neurology·2026

Same journal

Plasma D-dimer can predict malignant brain edema after thrombectomy in noncardioembolic acute cerebral infarction.

BMC neurology·2026

Same journal

Association of low-dose intra-arterial plus intravenous tirofiban with improved functional outcome in branch atheromatous disease-related stroke patients with early neurological deterioration.

BMC neurology·2026

See all related articles

Predicting Alzheimer's dementia progression in Mild Cognitive Impairment (MCI) is crucial. Integrating diverse biosignatures like MRI, genetics, and cognitive tests significantly improves prediction accuracy for MCI to Alzheimer's conversion.

Area of Science:

Neuroscience
Biomedical Data Science
Gerontology

Background:

Mild Cognitive Impairment (MCI) significantly increases the risk of progressing to Alzheimer's dementia.
Early identification of individuals with MCI likely to convert to dementia is a key focus in Alzheimer's research.
Multiple biosignatures, including neuroimaging, demographic, genetic, and cognitive data, offer complementary information for AD diagnosis and prognosis.

Purpose of the Study:

To evaluate the predictive power of integrating various baseline data for MCI to Alzheimer's dementia conversion.
To identify a concise set of key biosignatures for predicting MCI to AD conversion.
To assess the relative importance of different data modalities in predicting conversion.

Main Methods:

Utilized a large cohort of 319 MCI subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

More Related Videos

Basics of Multivariate Analysis in Neuroimaging Data

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

Related Experiment Videos

Last Updated: May 21, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Basics of Multivariate Analysis in Neuroimaging Data

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

Employed sparse logistic regression with stability selection for data integration and feature selection.

Integrated and analyzed diverse baseline data, including MRI, demographic, genetic (APOE genotyping), and cognitive measures.

Main Results:

A combination of 15 features from MRI, APOE genotyping, and cognitive measures achieved a high prediction accuracy (AUC score of 0.8587).
The study included 177 MCI Non-converters and 142 MCI Converters over a 4-year follow-up period.
The selected features demonstrated robust predictive capability for MCI to AD conversion.

Conclusions:

Integrating diverse baseline biosignatures is a powerful strategy for predicting MCI to probable Alzheimer's dementia conversion.
Sparse logistic regression with stability selection is an effective method for robust feature selection in this context.